Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

martes, 6 de enero de 2026, 9:52 am ET1 min de lectura
CMPX--

Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios